Unravelling Chronic Myeloid Leukaemia (CML): Insights from Dr. Jatin Sarin and Dr. Rimpi Sarin

Unraveling Chronic Myeloid Leukaemia (CML): Insights from Dr. Jatin Sarin and Dr. Rimpi Sarin

Chronic Myeloid Leukaemia (CML), the second most prevalent form of leukaemia, reveals a remarkable journey of optimism and promise. With a prognosis that shines brightly, boasting a 5-year survival rate surpassing 90%, CML represents a beacon of hope for patients and their families. The realm of CML treatment has evolved into an era of exceptional possibilities, where patients need only embrace a regimen of oral tablets for their path to recovery.

At our esteemed clinic, we stand at the forefront of this battle against CML. Our pioneering approach ensures that monitoring this condition is both comprehensive and seamless. Through the power of Bcr-abl testing and CBC analysis, we track every nuance of progress, leaving no stone unturned in the pursuit of well-being.

We understand the significance of accessible care. Our commitment to your health is exemplified by our clinic's offering of CML monitoring at a cost of ₹3500-4000/- every 3 months. Because your journey to victory over CML deserves nothing but the best.

Join us in embracing the possibilities, shattering limitations, and embarking on a path that leads to triumph over Chronic Myeloid Leukaemia.

CML- 2 nd most common leukaemia. Very good prognosis. 5- year survival is more than 90%. Very good treatment is available for CML. Pt has to take tablets only.
Monitoring of CML is done by Bcr- abl and CBC. Cost of monitoring at our clinic ₹3500-4000/- every 3 months.
Chronic Myeloid Leukaemia, CML Awareness, Oncology Insights, Medical Expertise, Dr. Jatin Sarin, Dr. Rimpi Sarin, [Institution Name], Leukaemia Treatment, Oncology Advances, Medical Education, Patient Care, Blood Cancer Awareness, CML Diagnosis, Oncology Specialists, Leukaemia Research, Medical Interview, Healthcare Information, Cancer Treatment Options, Expert Medical Advice, CML Management, Cancer Care, Medical Knowledge.